AD Scientific Index
 Open Nav
Login Login Pricing & Plans Pricing & Plans
Chih-Wei(Charlie) Lin

Chih-Wei(Charlie) Lin

Amgen Inc - Thousand Oaks / United States
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
AD Scientific Index ID: 4425046
-
person_outline Chih-Wei(Charlie) Lin's MOST POPULAR ARTICLES
1-) Glecaprevir–pibrentasvir for 8 or 12 weeks in HCV genotype 1 or 3 infection New England Journal of Medicine 378 (4), 354-369, 2018
2-) Glecaprevir plus pibrentasvir for chronic hepatitis C virus genotype 1, 2, 4, 5, or 6 infection in adults with compensated cirrhosis (EXPEDITION-1): a single-arm, open-label … The Lancet infectious diseases 17 (10), 1062-1068, 2017
3-) Glecaprevir and pibrentasvir yield high response rates in patients with HCV genotype 1–6 without cirrhosis Journal of hepatology 67 (2), 263-271, 2017
4-) Efficacy of glecaprevir/pibrentasvir for 8 or 12 weeks in patients with hepatitis C virus genotype 2, 4, 5, or 6 infection without cirrhosis Clinical Gastroenterology and Hepatology 16 (3), 417-426, 2018
5-) Glecaprevir and pibrentasvir for 12 weeks for hepatitis C virus genotype 1 infection and prior direct‐acting antiviral treatment Hepatology 66 (2), 389-397, 2017